HealthDay – MONDAY, Sept. 13 (HealthDay News) — A common asthma drug might
accelerate the benefits of treatment for multiple sclerosis when combined
with standard medicine, new research suggests.
View full post on Yahoo! News: Health News
HealthDay – MONDAY, Sept. 13 (HealthDay News) — A common asthma drug might
accelerate the benefits of treatment for multiple sclerosis when combined
with standard medicine, new research suggests.
View full post on Yahoo! News: Health News
MedIndia |
Asthma drug helps with Multiple sclerosis treatment
Health Jackal The results of a new study show that by adding albuterol, a drug normally used to treat asthma and other respiratory diseases, to an existing treatment for … Health Minute: Asthma medication helpful for MS patients Asthma drug can help treat MS Asthma Drug Can Prove Effective for MS Patients |
View full post on asthma – Google News
Researchers' discovery hints at new targets for asthma treatment
U-M Health System News In addition to providing a new paradigm to explain rhinovirus-induced asthma exacerbations, the work identifies new cellular and molecular targets for … |
View full post on asthma – Google News
Common Asthma Drug Could Speed MS Treatment
BusinessWeek 13 (HealthDay News) — A common asthma drug might accelerate the benefits of treatment for multiple sclerosis when combined with standard medicine, … Asthma drug albuterol improves multiple sclerosis when added to conventional … Asthma drug may help multiple sclerosis: study Asthma Drug May Help MS Patients |
View full post on asthma – Google News
For the Treatment of Asthma, Surveyed Safety-Minded Physicians May Be the Most …
MarketWatch (press release) According to the new report, Brand Perception Series: Physician Segmentation in Asthma, physicians report the greatest need in asthma treatment is for a … |
View full post on asthma – Google News
Press TV |
Iran finds Hypnosis treatment for asthma
Press TV Dr. Mahvash Agah says her team has made significant improvements in reducing the force of asthma attacks. The founder of Iran's first hypnotherapy clinic … |
View full post on asthma – Google News
Back to the Basics for Asthma Treatment
Ivanhoe (Ivanhoe Newswire) — Researchers say as many as 50 percent treatment-resistant asthma cases in kids are misdiagnosed. Many children will respond to therapy … |
View full post on asthma – Google News
Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States. By neutralizing a key toxin associated with the bacteria, they found they could greatly reduce the damaging effects of the infection on skin and soft tissue. Community strains of S. aureus cause infection in otherwise healthy people and are considered extremely virulent, as opposed to hospital strains that infect people who already are weakened by illness or surgery.
View full post on National Institutes of Health (NIH) News Releases
El Camino Hospital Offers Revolutionary New Asthma Treatment
Medical News Today (press release) "Bronchial thermoplasty is an important step forward for patients with severe asthma," said Dr. Krishna. "Not only does it result in a reduction in symptoms … |
View full post on asthma – Google News
On Sept. 2-3, 2010, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Diseases (NIAID), and the NIH Office of Research on Women’s Health (ORWH) will convene a two-day conference on Systemic Lupus Erythematosus: From Mouse Models to Human Disease and Treatment. This meeting will bring together basic research scientists working on models of autoimmune disease relevant to systemic lupus erythematosus (SLE), with clinicians treating lupus patients. There are numerous mouse models of lupus, but their relevance to the actual disorder is still a subject for debate. Moreover, since SLE is a heterogeneous disease, some features of the disorder may be better reflected in one or another mouse model.
View full post on National Institutes of Health (NIH) News Releases